Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
The DEA emergency scheduling controlled substances update includes the temporary placement of 2-fluorodeschloroketamine in Schedule I. This reflects regulatory efforts to address emerging synthetic drugs with abuse potential. Clinicians should monitor…
DEA Control of Synthetic Ketamine Analogs: 2-Fluorodeschloroketamine Scheduling
The DEA synthetic ketamine analog control includes the temporary Schedule I placement of 2-fluorodeschloroketamine (2-FDCK). This action addresses emerging synthetic drugs posing clinical and regulatory challenges. Clinicians should stay informed about…
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
The DEA scheduling updates include the temporary placement of 2-Fluorodeschloroketamine in Schedule I due to its abuse potential. This regulatory action highlights challenges in controlling novel synthetic substances. Clinicians should stay informed…